Publication | Open Access
Methods for the estimation of the NICE cost effectiveness threshold
123
Citations
0
References
2013
Year
Applied EconomicsClinical ExcellenceHealth EconomistsExperimental EconomicsEconomic AnalysisCost ManagementPublic HealthHealth Services ResearchQuantitative ManagementEconomicsQuality CostHealth PolicyHealth InsuranceCostly DrugsOutcomes ResearchCostbenefit AnalysisPharmacoeconomicsCost EffectivenessEconomic EvaluationHealthcare ValueMarketingCost IssueHealth EconomicsBusinessHealth Care CostMedicine
A study by health economists at the University of York has, for the first time, produced an estimate of the impact on other NHS patients of new and more costly drugs and other treatments. This research suggests a refinement of the way the National Institute for Health and Clinical Excellence (NICE) gauges the cost-effectiveness of new interventions. It also has implications for the prices that the NHS can afford to pay for new drugs when the value-based pricing scheme for all new drugs is introduced by the Government in 2014.